Experience with clozapine in a community mental health care setting

Southern Medical Journal

Volumn 91, Issue 9, 1998, Pages 838-841

  Connelly, John C ^a   Fullick, John ^b  

^a New Horizons Community Service Board   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMMUNITY CARE; DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; MENTAL DISEASE; MENTAL HEALTH CARE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; QUALITY OF LIFE; RESPIRATORY FUNCTION DISORDER; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0031714002     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199809000-00006     Document Type: Article

References (12)

1. Meltzer HY: Predictors of response to clozapine. Psychiatr Ann 1996; 26:385-389
2. Marder SR: Treatment of schizophrenia with typical antipsychotic drugs. J Clin Psychiatry 1996; 14:3-5
3. Breier A: Mechanism of action of clozapine. J Clin Psychiatry 1996; 14:6-8
4. Safferman A, Lieberman JA, Kane JM, et al: Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 1991; 17:105-120
5. Grace J, Bellus SB, Raulin ML, et al: Longterm impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functions. Psychiatr Serv 1996; 47:41-45
6. Kane J, Honigfeld G, Singer J, et al: Clozapine for the treatment resistant schizophrenic: a double blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
7. Chengappa KN, Gopalani A, Haught M, et al: The treatment of clozapine-associated agranulocytosis with granulocyte colony stimulating factor. Psychopharmacol Bull 1996; 32:111-120
8. Honigfeld G: The clozapine national registry system. J Clin Psychiatry 1996; 14:29-32
9. Lieberman JA, Safferman AZ, Pollock S, et al: Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 1994; 151:1744-1752
10. Meltzer HY, Okayli G: Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 1995; 152:183-190
11. McElroy SL, Dessain EC, Pope HG, et al: Clozapine in the treatment of psychotic mood disorders, schizoaffective disorders and schizophrenia. J Clin Psychiatry 1991; 52:411-414
12. Perry PJ, Miller DO, Arndt SV, et al: Clozapine and norclozapine plasma concentrations and clinical responses of treatment refractory schizophrenic patients. Am J Psychiatry 1991; 148:231-235